InvestSMART

Nyrada Inc (ASX: NYR) - Announcements

Current share price for NYR : $0.500 0.045 (8.26%)+

ASX company news and announcements for Nyrada Inc (NYR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nyrada Inc (NYR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nyrada Inc (NYR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nyrada Inc (NYR)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$129 Nyrada Phase IIa Clinical Trial Update 18 Nov 2025 10:54AM $0.655 $0.500 fallen by 23.66%
$129 Cleansing Statement 13 Nov 2025 11:37AM $0.665 $0.500 fallen by 24.81%
$129 Application for quotation of securities - NYR 13 Nov 2025 11:35AM $0.665 $0.500 fallen by 24.81%
$129 Final Director's Interest Notice 12 Nov 2025 4:58PM $0.730 $0.500 fallen by 31.51%
$129 Change of Director's Interest Notice 12 Nov 2025 4:53PM $0.730 $0.500 fallen by 31.51%
$129 Notification of cessation of securities - NYR 12 Nov 2025 4:19PM $0.730 $0.500 fallen by 31.51%
$129 Results of Meeting 12 Nov 2025 12:41PM $0.750 $0.500 fallen by 33.33%
$129 AGM Chair Address 12 Nov 2025 8:23AM $0.790 $0.500 fallen by 36.71%
$129 AGM Presentation 12 Nov 2025 8:23AM $0.790 $0.500 fallen by 36.71%
$129 Investor Presentation and CEO AGM Presentation 10 Nov 2025 8:26AM $0.790 $0.500 fallen by 36.71%
$129 Upcoming Release of Securities from Voluntary Escrow 7 Nov 2025 4:44PM $0.790 $0.500 fallen by 36.71%
$129 Cleansing Statement 5 Nov 2025 4:55PM $0.900 $0.500 fallen by 44.44%
$129 Application for quotation of securities - NYR 5 Nov 2025 4:53PM $0.900 $0.500 fallen by 44.44%
$129 Cleansing Statement 3 Nov 2025 4:18PM $0.770 $0.500 fallen by 35.06%
$129 Application for quotation of securities - NYR 3 Nov 2025 4:16PM $0.770 $0.500 fallen by 35.06%
$129 Cleansing Statement 22 Oct 2025 4:30PM $0.325 $0.500 risen by 53.85%
$129 Application for quotation of securities - NYR 22 Oct 2025 4:27PM $0.325 $0.500 risen by 53.85%
$129 Quarterly Activities Report and Appendix 4C 21 Oct 2025 12:40PM $0.365 $0.500 risen by 36.99%
$129 Nyrada Selects Accelagen as CRO for Phase IIa Clinical Trial 13 Oct 2025 5:55PM $0.350 $0.500 risen by 42.86%
$129 Notification of cessation of securities - NYR 8 Oct 2025 4:57PM $0.295 $0.500 risen by 69.49%
$129 2025 AGM Letter to Shareholders, Notice of Meeting & Proxy 8 Oct 2025 9:52AM $0.295 $0.500 risen by 69.49%
$129 Initial Director's Interest Notice - JB 8 Oct 2025 9:43AM $0.295 $0.500 risen by 69.49%
$129 Nyrada Board Transition and CEO Remuneration Review 8 Oct 2025 9:41AM $0.295 $0.500 risen by 69.49%
$129 Cleansing Statement 2 Oct 2025 4:31PM $0.320 $0.500 risen by 56.25%
$129 Application for quotation of securities - NYR 2 Oct 2025 4:28PM $0.320 $0.500 risen by 56.25%

101 - 125 of 514 results

Page 5 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.